Skip to content

Narrow window to avert HIV epidemics among MSM in Middle East and North Africa

Low but detectable viral load during HIV treatment involves a risk of resistance

Poor CD4 cell recovery after starting HIV treatment should be a cause for concern, close monitoring needed

IAS 2011 conference: summary

Operational research: diagnostics and task-shifting

Pre-exposure prophylaxis

Retention of pre-ART patients poor in sub-Saharan Africa

Boceprevir response and resistance differs according to HCV genotype 1 subtype

Daria Hazuda from Merck. ©IAS/Marcus Rose/Worker's Photos